iBio IBIO
NASDAQ IBIO
$1.13 -0.04 (-3.80%)
As of: Oct 1, 2026 · 2:02 PM EDT

iBio (IBIO) Gross Margin (2020 - 2022)

Updated

iBio (IBIO) reported Gross Margin of 115.02% for FY2022 (year ended Jun 30, 2022), up 76.68 percentage points from 38.34% in FY2021.

Analysis

iBio (IBIO) Gross Margin (2020 - 2022) Analysis & Trends

  • According to Business Quant data, Gross Margin came in at 38.34% in FY2021 (-18.74 pp) and 57.08% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 68.19%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 74.74%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 78.02%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 83.60%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 72.04%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 79.76%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 85.33%
10 iBio 122.79 Mn 122.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 105.28%
Sep 30, 2021 203.57%
Jun 30, 2021 61.91%
Mar 31, 2021 35.56%
Dec 31, 2020 70.07%
Sep 30, 2020 73.90%
Jun 30, 2020 73.30%
Mar 31, 2020 10.42%
API Access

iBio Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=IBIO&period=max&api_key=YOUR_API_KEY